61 Results

People

  1. Kelsen
    Kelsen
  2. Casper
    Casper
  3. Aghajanian
    Aghajanian
  4. Schwartz
    Schwartz
  5. Bajorin
    Bajorin
  6. De Angelis
    De Angelis
  7. Lassman
    Lassman
  8. Motzer
    Motzer
  9. O'Reilly
    O'Reilly
  10. Abou-Alfa
    Abou-Alfa

Groups

  1. Department of Medicine (45)
  2. Solid Tumor Oncology Division (34)
  3. Hematologic Malignancies, Division of (13)
  4. Center for Pancreatic Cancer Research (11)
  5. Gastrointestinal Oncology Service (9)
  6. Biostatistics Service (8)
  7. Center for Hematologic Malignancies (8)
  8. Epidemiology and Biostatistics (8)
  9. Genitourinary Oncology Service (8)
  10. Surgery (8)
  1. "phase ii"
Formats
  1. Journal Article (49)
  2. Meeting Abstract (12)
Groups
  1. Department of Medicine (45)
  2. Solid Tumor Oncology Division (34)
  3. Hematologic Malignancies, Division of (13)
  4. Center for Pancreatic Cancer Research (11)
  5. Gastrointestinal Oncology Service (9)
  6. Biostatistics Service (8)

More Groups

People
  1. David Kelsen (7)
  2. Ephraim Casper (6)
  3. Carol Aghajanian (5)
  4. Gary Schwartz (5)
  5. Dean Bajorin (4)
  6. Andrew Lassman (3)

More People

Years
  1. 2024 (2)
  2. 2023 (8)
  3. 2022 (4)
  4. 2019 (2)
  5. 2018 (1)
  6. 2017 (1)

More Years

Publications
  1. Investigational New Drugs (14)
  2. Clinical Lymphoma, Myeloma and Leukemia (11)
  3. Gynecologic Oncology (6)
  4. International Journal of Radiation Oncology, Biology, Physics (5)
  5. Cancer (3)
  6. European Journal of Cancer (3)

More Publications

Publishers
  1. Elsevier Inc. (28)
  2. Springer (16)
  3. Oxford University Press (3)
  4. Wiley Blackwell (3)
  5. Elsevier Science, Inc. (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (61)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer
    Journal Article

    Schellenberg, D.; Kim, J.; Christman-Skieller, C.; Chun, C. L.; Columbo, L. A.; Ford, J. M.; Fisher, G. A.; Kunz, P. L.; Van Dam, J.; Quon, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer
    Journal Article

    Krug, L. M.; Crawford, J.; Ettinger, D. S.; Shapiro, G. I.; Spigel, D.; Reiman, T.; Temel, J. S.; Michelson, G. C.; Young, D. Y.; Hoch, U.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Baxi, S.; Shen, R.; Kelly, K. W.; Lipson, B. L.; Carlson, D.; Stambuk, H.; Haque, S.; Pfister, D. G.
    Anticancer Research (2011)

    Fulltext@MSK | Save
  • A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603)
    Journal Article

    O'Reilly, E. M.; Niedzwiecki, D.; Hall, M.; Hollis, D.; Bekaii-Saab, T.; Pluard, T.; Douglas, K.; Abou-Alfa, G. K.; Kindler, H. L.; Schilsky, R. L.; more...
    The Oncologist (2010)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
    Journal Article

    Feldman, D. R.; Turkula, S.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Carousso, M.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2010)

    Fulltext@MSK | Save
  • Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash
    Journal Article

    Schilder, R. J.; Pathak, H. B.; Lokshin, A. E.; Holloway, R. W.; Alvarez, R. D.; Aghajanian, C.; Min, H.; Devarajan, K.; Ross, E.; Drescher, C. W.; more...
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma
    Journal Article

    Patel, P. H.; Kondagunta, G. V.; Schwartz, L.; Ishill, N.; Bacik, J.; Deluca, J.; Russo, P.; Motzer, R. J.
    Investigational New Drugs (2008)

    Fulltext@MSK | Save
  • A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer
    Journal Article

    Konner, J.; Schilder, R. J.; DeRosa, F. A.; Gerst, S. R.; Tew, W. P.; Sabbatini, P. J.; Hensley, M. L.; Spriggs, D. R.; Aghajanian, C. A.
    Gynecologic Oncology (2008)

    Fulltext@MSK | Save
  • Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810)
    Journal Article

    Kalmadi, S. R.; Rankin, C.; Kraut, M. J.; Jacobs, A. D.; Petrylak, D. P.; Adelstein, D. J.; Keohan, M. L.; Taub, R. N.; Borden, E. C.
    Lung Cancer (2008)

    Fulltext@MSK | Save
  • Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma
    Journal Article

    Straus, D. J.; Duvic, M.; Kuzel, T.; Horwitz, S.; Demierre, M. F.; Myskowski, P.; Steckel, S.
    Cancer (2007)

    Fulltext@MSK | Save